Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Sleep Medicine

The Search for Answers: Navigating the Sleep Study and MSLT

At a Glance

Narcolepsy type 2 diagnosis depends on at least three months of daily, irresistible sleepiness, no cataplexy or better explanation, and a properly prepared overnight sleep study followed by MSLT showing an average sleep latency of 8 minutes or less and at least two sleep-onset REM periods.

The process of diagnosing Narcolepsy Type 2 (NT2) is more than just feeling sleepy. It requires a precise set of clinical criteria and objective measurements to ensure that the sleepiness isn’t caused by something else [1][2]. Because NT2 lacks a biological “marker” like the low hypocretin levels found in Type 1, the diagnosis relies heavily on a clinical evaluation and a two-part sleep study: an overnight polysomnogram (PSG) followed immediately by a Multiple Sleep Latency Test (MSLT) [1][3].

The Formal Requirements

To meet the official criteria for NT2, you must have experienced daily, irrepressible sleepiness for at least three months, without cataplexy, and with no better explanation from insufficient sleep, circadian misalignment, another sleep disorder, or substance use [1]. During your sleep studies, doctors look for specific markers as part of this complete diagnostic process:

  1. Mean Sleep Latency: You must fall asleep in an average of 8 minutes or less across four or five nap opportunities [1][2].
  2. SOREMPs: These are sleep-onset REM periods. You must enter REM sleep (the dreaming stage) within 15 minutes of falling asleep at least two times during your naps [1].
  3. The Overnight “Bonus”: If you enter REM sleep within 15 minutes of sleep onset during the overnight study (a nocturnal SOREMP), this can count as one of your two required REM periods [1][4].

Why Accuracy is a Challenge

The MSLT is a “snapshot” of your sleepiness on a single day, and for NT2, that snapshot can be surprisingly unstable. Unlike Type 1 narcolepsy, which remains generally more stable over time, NT2 test results can fluctuate based on many factors [5][6].

Research shows that diagnostic agreement upon repeat testing can be low (e.g., 18% to 47% in some studies) [6][5]. Many patients might test as having “Idiopathic Hypersomnia” on one day and “Narcolepsy Type 2” on another, while others may even have a negative test result despite still feeling exhausted [6][7].

The “Completeness Checklist” for a Valid Test

Because the MSLT is so sensitive, several factors can confound the results, making it look like you have narcolepsy when your sleepiness is actually caused by something else [8][9]. To ensure your diagnosis is accurate, your medical team should follow this “Completeness Checklist” before and during your testing:

  • Rule Out Other Disorders: Conditions like Obstructive Sleep Apnea (OSA), shift work, and circadian rhythm delay must be considered. If you have OSA, it must be effectively treated with documented adequate adherence before you are tested for narcolepsy [10][11].
  • Two Weeks of Sleep Tracking: You should maintain adequate, habitual sleep for at least two weeks before the test, following your clinician’s protocol [10]. Doctors often use actigraphy (a medical-grade wrist tracker) and sleep diaries to prove you weren’t just sleep-deprived during the study [10][12].
  • Medication Withdrawal: Many common medications—especially antidepressants—can suppress REM sleep and produce a false-negative result, while abrupt discontinuation can cause a REM rebound that produces false-positive SOREMPs [10][13]. Stimulants alter alertness. Every medication and supplement should be reviewed and tapered only under the prescriber’s individualized plan; do not stop them abruptly [10][14].
  • Substance History and Toxicology: A medication and substance history is taken, and a drug screen is sometimes performed on the morning of the MSLT, to detect substances like cannabis, opioids, or amphetamines that can confound MSLT results [10][15]. (Routine toxicology does not reliably measure caffeine or nicotine, so these must be discussed with your doctor).

When to Consider Repeat Testing

Because NT2 is a “diagnosis of exclusion,” your doctor might suggest a repeat study if your initial results were borderline or if your symptoms change significantly—such as if you begin to experience muscle weakness (cataplexy) [6][16]. If your first test was done while you were taking certain medications or while your sleep was irregular, a repeat test under optimized conditions is often necessary [16]. Your diagnosis is a journey, and the goal of these strict steps is to ensure you receive the right treatment for your specific type of sleepiness.

Common questions in this guide

How is narcolepsy type 2 diagnosed?
Narcolepsy type 2 is considered when a person has daily, irresistible daytime sleepiness for at least three months, no cataplexy, and no better explanation such as inadequate sleep or another sleep disorder. Diagnosis usually combines an overnight polysomnogram with a Multiple Sleep Latency Test, or MSLT.
What MSLT results support a diagnosis of narcolepsy type 2?
The MSLT measures how quickly you fall asleep during four or five scheduled naps and whether you enter REM sleep within 15 minutes. Results support narcolepsy type 2 when average sleep latency is 8 minutes or less and at least two sleep-onset REM periods occur, provided other causes have been addressed. A qualifying REM period during the overnight study may count as one of the two.
How should I prepare for a narcolepsy type 2 sleep study?
Your clinician may ask you to maintain adequate, regular sleep for at least two weeks and document it with sleep diaries or actigraphy, a medical-grade wrist tracker. Sleep apnea and other sleep disorders should be evaluated and treated, and all medications, supplements, and substances should be reviewed before testing.
Can medications affect my MSLT results?
Yes. Antidepressants may suppress REM sleep and cause a false-negative result, while abruptly stopping them can cause REM rebound and produce misleading positive findings; stimulants can also change alertness. Never stop or taper a medication without an individualized plan from the prescribing clinician.
Why might my narcolepsy type 2 test need to be repeated?
MSLT results can vary from one test to another, especially when sleep was irregular, another sleep disorder was untreated, or medications affected REM sleep or alertness. A repeat study may be considered when the first results are borderline, symptoms change, or cataplexy develops.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my mean sleep latency and exactly how many SOREMPs were recorded during my naps and overnight study?
  2. 2.Did my overnight PSG show any signs of sleep apnea or other issues that could have made me sleepier during the daytime test?
  3. 3.If we didn't use actigraphy (the wrist-worn tracker) before my study, how can we be sure that my sleep schedule didn't skew the results?
  4. 4.Were there any medications I was taking—like antidepressants or stimulants—that might have suppressed my REM sleep and affected the test?
  5. 5.If my symptoms don't improve or they change significantly, at what point would we consider a repeat study?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Narcolepsies, update in 2023.

    Barateau L, Pizza F, Chenini S, et al.

    Revue neurologique 2023; (179(7)):727-740 doi:10.1016/j.neurol.2023.08.001.

    PMID: 37634997
  2. 2

    The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.

    Ruoff C, Rye D

    Current medical research and opinion 2016; (32(10)):1611-1622 doi:10.1080/03007995.2016.1208643.

    PMID: 27359185
  3. 3

    Central disorders of hypersomnolence - A narrative review on current and potential biomarkers.

    Tai JE, Sivam S, D'Rozario A, et al.

    Sleep medicine reviews 2025; (84()):102167 doi:10.1016/j.smrv.2025.102167.

    PMID: 40976193
  4. 4

    Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: a study in a Japanese cohort.

    Kawai R, Watanabe A, Fujita S, et al.

    Sleep medicine 2020; (68()):9-17 doi:10.1016/j.sleep.2019.04.008.

    PMID: 31999982
  5. 5

    Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.

    Lopez R, Doukkali A, Barateau L, et al.

    Sleep 2017; (40(12)) doi:10.1093/sleep/zsx164.

    PMID: 29099966
  6. 6

    The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.

    Ruoff C, Pizza F, Trotti LM, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2018; (14(1)):65-74 doi:10.5664/jcsm.6882.

    PMID: 29198301
  7. 7

    A Longitudinal Follow-Up Study on Multiple Sleep Latency Test and Body Mass Index of Patients With Narcolepsy Type 1 in Korea.

    Um YH, Kim TW, Jeong JH, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2017; (13(12)):1441-1444 doi:10.5664/jcsm.6844.

    PMID: 29117886
  8. 8

    Narcolepsy type 2: A rare, yet existing entity.

    Baumann-Vogel H, Schreckenbauer L, Valko PO, et al.

    Journal of sleep research 2021; (30(3)):e13203 doi:10.1111/jsr.13203.

    PMID: 32989797
  9. 9

    Diagnosing narcolepsy in the active duty military population.

    Villarreal B, Powell T, Brock MS, Hansen S

    Sleep & breathing = Schlaf & Atmung 2021; (25(2)):995-1002 doi:10.1007/s11325-020-02163-5.

    PMID: 33629215
  10. 10

    Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine.

    Krahn LE, Arand DL, Avidan AY, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(12)):2489-2498 doi:10.5664/jcsm.9620.

    PMID: 34423768
  11. 11

    Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy.

    Foster SN, Hansen SL, Scalzitti NJ, et al.

    Sleep & breathing = Schlaf & Atmung 2020; (24(1)):143-150 doi:10.1007/s11325-019-01830-6.

    PMID: 30953233
  12. 12

    Actigraphy prior to Multiple Sleep Latency Test: nighttime total sleep time predicts sleep-onset latency.

    Kelly MR, Zeidler MR, DeCruz S, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022; (18(1)):161-170 doi:10.5664/jcsm.9528.

    PMID: 34310278
  13. 13

    Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency.

    Kolla BP, Jahani Kondori M, Silber MH, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(11)):1921-1927 doi:10.5664/jcsm.8738.

    PMID: 32780009
  14. 14

    The influence of antidepressants and actigraphy-derived sleep characteristics on pediatric multiple sleep latency testing.

    Mansukhani MP, Dhankikar S, Kotagal S, Kolla BP

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(11)):2179-2185 doi:10.5664/jcsm.9338.

    PMID: 34013880
  15. 15

    Urine Toxicology in Adults Evaluated for a Central Hypersomnia and How the Results Modify the Physician's Diagnosis.

    Kosky CA, Bonakis A, Yogendran A, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2016; (12(11)):1499-1505 doi:10.5664/jcsm.6276.

    PMID: 27568897
  16. 16

    Test-retest repeatability of the multiple sleep latency test in non-cataleptic hypersomnolence disorders.

    Johnson J, Grigg-Damberger M, El Ahdab J, et al.

    Sleep medicine 2026; (142()):108876 doi:10.1016/j.sleep.2026.108876.

    PMID: 41780441

This page explains how sleep studies and MSLT results are used to evaluate narcolepsy type 2 for informational purposes only and does not constitute medical advice. Your sleep specialist should interpret your results and guide any medication changes or repeat testing.

Get notified when new evidence is published on Narcolepsy type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.